STAT

Opinion: Tuberculosis is a disease the world could control. But will it?

#Tuberculosis is relentless and cruel, and lately it has been winning. But it doesn't stand a chance if the world comes together to fight back.
A woman in India with tuberculosis prepares to take a dose of medicines at the TB Unit of the Baherampura District Microscopic Centre in Ahmedabad.

When Juan Paucar Yareta was diagnosed with tuberculosis, he was living with his son, daughter-in-law, and granddaughter on the fringes of Lima, Peru. The 57-year-old electrician started taking the standard treatment for this airborne infectious disease in 2003, but the disease kept its grip on him and he continued to lose weight. His doctors switched him to different medications. And then switched again. At some point, his tuberculosis had grown resistant to the so-called first-line tuberculosis drugs.

As Juan continued to waste away, he lost his job but

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks